Percutaneous mitral edge-to-edge repair provides a viable treatment option for high-surgical-risk patients with severe symptomatic mitral regurgitation, though clinical benefits depend on careful patient selection.
Does percutaneous edge-to-edge repair improve clinical outcomes in patients with severe symptomatic mitral regurgitation who are not eligible for mitral valve surgery?
Percutaneous edge-to-edge repair represents an important treatment option for patients with severe symptomatic mitral regurgitation who are ineligible for surgery.
Patients with severe symptomatic mitral regurgitation have a poor prognosis if left untreated. In those patients who are not eligible for mitral valve surgery, percutaneous edge-to-edge repair may improve clinical outcomes. Recent clinical trials have added to our knowledge and provide interesting insights into the management of such patients. With an increasingly aging global population, these technologies are likely to represent an important treatment option. This mini-review will examine the technology, the evidence and the latest developments in percutaneous mitral edge-to-edge repair.
Khan et al. (Wed,) conducted a review in Severe symptomatic mitral regurgitation. Percutaneous mitral edge-to-edge repair was evaluated. Percutaneous mitral edge-to-edge repair provides a viable treatment option for high-surgical-risk patients with severe symptomatic mitral regurgitation, though clinical benefits depend on careful patient selection.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: